> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Latest Federal Register Notices
- URL: https://www.fdaweb.com/latest-federal-register-notices-215/
- Published: 2019-03-17T12:00:00.000Z
- Updated: 2026-09-15T01:13:17.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5143635

[**Clinical Trial Enrichment Strategies Guide**](https://www.fdaweb.com/clinical-trial-enrichment-strategies-guide/)  
Federal Register notice: FDA makes available a final guidance entitled “Enrichment Strategies for Clinical Trials to Support Demonstration of Effectiveness of Human Drugs and Biological Products.” 03/15/2019 

[**Guide on Hematologic Disorders Drug Development**](https://www.fdaweb.com/guide-on-hematologic-disorders-drug-development/)  
Federal Register notice: FDA makes available a final guidance entitled “Severely Debilitating or Life-Threatening Hematologic Disorders: Nonclinical Development of Pharmaceuticals.” 03/15/2019 

[**Draft Guide on Clinical Trial Sponsor Monitoring**](https://www.fdaweb.com/draft-guide-on-clinical-trial-sponsor-monitoring/)  
Federal Register notice: FDA makes available a draft guidance entitled “A Risk-Based Approach to Monitoring of Clinical Investigations: Questions and Answers.” 03/15/2019 

[**Guidance on Animal-sourced Materials in Devices**](https://www.fdaweb.com/guidance-on-animal-sourced-materials-in-devices/)  
Federal Register notice: FDA makes available a final guidance on “Medical Devices Containing Materials Derived from Animal Sources (Except for In Vitro Diagnostic Devices).” 03/15/2019 

[**Info Collection Extension for Accredited Person Inspections**](https://www.fdaweb.com/info-collection-extension-for-accredited-person-inspections/)  
Federal Register notice: FDA seeks comments on an information collection extension for “Inspection by Accredited Persons Program Under the Medical Device User Fee and Modernization Act of 2002.” 03/14/2019 

[**FDA Updates ‘Modifications to the List of Recognized Standards’**](https://www.fdaweb.com/fda-updates-modifications-to-the-list-of-recognized-standards/)  
Federal Register notice: FDA posts an updated “Modifications to the List of Recognized Standards, Recognition List Number: 051.” 03/14/2019 

[**Draft Guide on Cancer Trials Eligibility for HIV Patients**](https://www.fdaweb.com/draft-guide-on-cancer-trials-eligibility-for-hiv-patients/)  
Federal Register notice: FDA makes available a draft guidance entitled “Cancer Clinical Trial Eligibility Criteria: Patients with HIV, Hepatitis B Virus, or Hepatitis C Virus Infections.” 03/14/2019 

[**Animal Drug Regs Amended to Reflect Application Actions**](https://www.fdaweb.com/animal-drug-regs-amended-to-reflect-application-actions/)  
Federal Register notice: FDA amends its animal drug regulations to reflect application-related actions for new animal drug applications and abbreviated new animal drug applications during July, August, and September 2018\. 03/14/2019 

[**Draft Guide on Pediatric Cancer Trial Eligibility**](https://www.fdaweb.com/draft-guide-on-pediatric-cancer-trial-eligibility/)  
Federal Register notice: FDA makes available a draft guidance entitled “Cancer Clinical Trial Eligibility Criteria: Minimum Age for Pediatric Patients.” 03/13/2019